FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved Dr. Reddy's supplemental application to manufacture and market aripiprazole orally disintegrating tablets as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• Aripiprazole ODT (aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE ORALLY DISINTEGRATING)